Cognitive Dysfunction in Fibromyalgia Patients

NCT01655537 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2013-09-17

No results posted yet for this study

Summary

Fibromyalgia is a common rheumatologic disorder. Many patients complain of cognitive dysfunction as part of their symptoms.

The investigators aim to assess this cognitive dysfunction through extensive neuro-cognitive testing.

Conditions

  • Fibromyalgia

Sponsors & Collaborators

  • Hadassah Medical Organization

    lead OTHER

Principal Investigators

  • RENA COOPER-KAZAZ, Dr. · Hadassah Medical Organization

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01655537 on ClinicalTrials.gov